&nbsp;

May 2018

Drug

cytarabine

Other Name(s): Cytosar® (multiple brands available)

Quick Link(s):

May 2018

Drug

mitoXANTRONE

Other Name(s): Novantrone® (multiple brands available)

Quick Link(s):

May 2018

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2017

Status: Current
ID: PET 2017-2
Version: n/a

May 2018

Regimen

CHOP

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Curative

Funding:

ODB - General Benefit

prednisone

, Collapse Show fewer tags

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2018

Guidelines and Advice

Gastroscopy Standards and Quality Indicators for Ontario

Status: Current

May 2018

Guidelines and Advice

Guidance for the Development of a Provincial Approach to Toxicity Management Summary of Recommendations from the Toxicity Management Advisory Committee

Status: Current
ID: N/A
Version: Final

May 2018

Drug

olaparib

Other Name(s): Lynparza®

Quick Link(s):

Jan 2025

Regimen

CAPIFLVS

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

fulvestrant

, Collapse Show fewer tags

Drugs Used:

capivasertib (Unfunded),

fulvestrant

... Show more tags

Quick Link(s):

Regimen Monograph

Jan 2025

Drug

enfortumab vedotin

Other Name(s): Padcev®

Quick Link(s):

Jan 2025

Regimen

ENFO

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Funding:

New Drug Funding Program

Enfortumab Vedotin - Previously Treated Advanced or Metastatic Urothelial Cancer